Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: A large observational study under conditions of daily practice

Current Medical Research and Opinion

Volumn 26, Issue 6, 2010, Pages 1377-1387

  Schutter, U ^a   Grunert, S ^b   Meyer, C ^c   Schmidt, T ^c   Nolte, T ^d  

^a Schmerztherapeutische Schwerpunktpraxis   (Germany)

^b Pain Specialist   (Germany)

^c MUNDIPHARMA GMBH   (Germany)

^d Pain and Palliative Care Centre Wiesbaden   (Germany)

Author keywords

Bowel function; Chronic pain; Constipation; Improved tolerability; Naloxone; Oxycodone; Quality of life

Indexed keywords

DICLOFENAC; DIPYRONE; IBUPROFEN; NALOXONE PLUS OXYCODONE; NARCOTIC ANALGESIC AGENT; TARGIN; UNCLASSIFIED DRUG;

AGED; ANALGESIA; ARTICLE; ATTENTION DISTURBANCE; BRIEF PAIN INVENTORY; CHRONIC PAIN; CLINICAL TRIAL; CONSTIPATION; DISEASE SEVERITY; DIZZINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; INJURY; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYOCLONUS; NAUSEA; NEOPLASM; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; PRESCRIPTION; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; SOMNOLENCE; SYNCOPE; UPPER ABDOMINAL PAIN; VOMITING; WITHDRAWAL SYNDROME;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; FEMALE; GERMANY; HUMANS; INTESTINES; MALE; MIDDLE AGED; NALOXONE; OXYCODONE; PAIN; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 77952466471     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007991003787318     Document Type: Article

References (17)

1. Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 2001;182:11-18S
2. Bell TJ, Panchal SJ, Miaskowski C, et al. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med 2009;10:35-42
3. De Schepper HU, Cremonini F, Park MI, Camilleri M. Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil 2004;16:383-394
4. Panchal SJ, Müller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract 2007; 61:1181-1187
5. Kaufman PN, Krevsky B, Malmud LS, et al. Role of opiate receptors in the regulation of colonic transit. Gastroenterology 1988;94:1351-1356
6. Crabtree BL. Review of naltrexone, a long-acting opiate antagonist. Clin Pharm 1984;3:273-280
7. Meissner W, Leyendecker P, Mueller-Lissner S, et al. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain 2009;13:56-64
8. Vondrackova D, Leyendecker P, Meissner W, et al. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain. J Pain 2008;9:1144-1154
9. Simpson K, Leyendecker P, Hopp M, et al. Fixed-ratio combination oxyco-done/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain. Curr Med Res Opin 2008;24:3503-3512
10. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-138
11. Leyendecker P, Hopp M, Bosse B, et al. Bowel function index-a new validated questionnaire for assessing opioid induced constipation. Proceedings of the IASP 12th World Congress on Pain 2008 Aug 17-22; Glasgow, Scotland
12. Mü ller-Lissner S, Leyendecker P, Hopp M, et al. Oral prolonged release oxycodone/naloxone combination reduces opioid-induced constipation in patients with severe chronic pain. 2nd International Congress on Neuropathic Pain, Berlin Germany 7-10 June 2007
13. Wörz R, Frank M, Achenbach U. Retardiertes Oxycodon-eine Therapieoption bei starken neuropatischen Schmerzen. Zwei multizentrische Anwendungsbeobachtungen. MMW Fortschr Med 2003;145(Suppl 3):71-76
14. Citron ML. Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain. Cancer Invest 1998;16:562-571
15. Emrich O. Effektive Schmerzlinderung und Wiederherstellung der Beweglichkeit bei Schmerzen unterschiedlicher Genese. Ergebnisse einer Beobachtungsstudie mit Oxycodon. MMW 2007;148:157-161
16. Hale, ME, Fleischmann R, Salzman R, et al. Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain. Clin J Pain 1999;15:179-183
17. Nadstawek J, Leyendecker P, Hopp M, et al. Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain. Int J Clin Pract 2008;62:1159-1167